Momordica charantia: a review of Its effects on metabolic diseases and mechanisms of action. - GreenMedInfo Summary
A Review of Its Effects on Metabolic Diseases and Mechanisms of Action.
J Med Food. 2021 Mar 17. Epub 2021 Mar 17. PMID: 33733863
Marisol Cortez-Navarrete
The global rise in the prevalence of metabolic diseases such as diabetes, obesity, and dyslipidemia is a serious public health issue. The search for safe and effective complementary and alternative therapies to treat metabolic disorders is a key field of research.(MC) is a tropical and subtropical vine of the Cucurbitaceae family used as a medicinal plant since ancient times. Although MC has been widely studied for its hypoglycemic potential, hypolipidemic and antiobesity effects have also been reported in preclinical studies and clinical trials. This study aims to review the metabolic effects of MC reported in clinical trials as well as its mechanisms of action.